Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |